Search Within

Ronald A Ghossein

  1. "Head and Neck Service"
Formats
  1. Journal Article (38)
  2. Meeting Abstract (21)
  3. Editorial (1)
  4. Guidelines (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (62)
  2. Department of Pathology and Laboratory Medicine (62)
  3. Head and Neck Service (62)
  4. Solid Tumor Oncology Division (62)
  5. GSK Faculty (36)
  6. Division of Subspecialty Medicine (35)

More Groups

People
  1. Alan Ho (37)
  2. Eric Sherman (35)
  3. David Pfister (29)
  4. James Fagin (27)
  5. Robert Tuttle (20)
  6. Nora Katabi (18)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (6)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Modern Pathology (5)
  3. Cancer (4)
  4. Thyroid (4)
  5. American Journal of Surgical Pathology (3)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Association for Cancer Research (8)
  3. Wiley Blackwell (8)
  4. Nature Research (5)
  5. Elsevier Inc. (4)
  6. Mary Ann Liebert, Inc (4)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): A randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
    Journal Article

    Sherman, E. J.; Harris, J.; Bible, K. C.; Xia, P.; Ghossein, R. A.; Chung, C. H.; Riaz, N.; Gunn, G. B.; Foote, R. L.; Yom, S. S.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of durvalumab (MEDI4736) with tremelimumab in combination with image-guided stereotactic body radiotherapy in the treatment of metastatic anaplastic thyroid cancer
    Journal Article

    Lee, N. Y.; Riaz, N.; Wu, V.; Brinkman, T.; Tsai, C. J.; Zhi, W.; Fetten, J.; Ho, A.; Wong, R. J.; Ghossein, R.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Head and neck acinic cell carcinoma: A new grading system proposal and diagnostic utility of NR4A3 immunohistochemistry
    Journal Article

    Xu, B.; Saliba, M.; Ho, A.; Viswanathan, K.; Alzumaili, B.; Dogan, S.; Ghossein, R.; Katabi, N.
    American Journal of Surgical Pathology (2022)

    Fulltext@MSK | Save
  • American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment
    Guidelines

    Shonka, D. C. Jr; Ho, A.; Chintakuntlawar, A. V.; Geiger, J. L.; Park, J. C.; Seetharamu, N.; Jasim, S.; Abdelhamid Ahmed, A. H.; Bible, K. C.; Brose, M. S.; more...
    Head & Neck (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Primary high-grade non-anaplastic thyroid carcinoma: A retrospective study of 364 cases
    Journal Article

    Xu, B.; David, J.; Dogan, S.; Landa, I.; Katabi, N.; Saliba, M.; Khimraj, A.; Sherman, E. J.; Tuttle, R. M.; Tallini, G.; more...
    Histopathology (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic correlates of thyroid carcinoma evolution after BRAF inhibitor therapy
    Journal Article

    Lee, M.; Untch, B. R.; Xu, B.; Ghossein, R.; Han, C.; Kuo, F.; Valero, C.; Nadeem, Z.; Patel, N.; Makarov, V.; more...
    Molecular Cancer Research (2022)

    Fulltext@MSK | Save